(Q51013219)
Statements
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study (English)
Peter Bartenstein
Henryk Barthel
Hermann-Josef Gertz
Stefan Dresel
Oliver Peters
Katharina Buerger
Sabine M Wittemer-Rump
John Seibyl
Cornelia Reininger
Osama Sabri
Florbetaben Study Group